Here are what the editors at HealthDay consider to be the most important developments in Surgery for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Liver Transplant Wait List May Not Prioritize High-Risk Patients
THURSDAY, Jan. 31, 2019 (HealthDay News) — The current method for ranking patients on the liver transplantation wait list may not prioritize some of the sickest candidates, according to a study recently published online in Gastroenterology.
Death at 10 Years Similar With Bilateral-, Single-Artery CABG
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — There is no difference in the rate of death from any cause at 10 years for patients undergoing coronary artery bypass grafting (CABG) with bilateral or single internal-thoracic-artery grafting, according to a study published in the Jan. 31 issue of the New England Journal of Medicine.
Thymectomy + PDN Beneficial for Non-Thymomatous Myasthenia Gravis
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — For patients with non-thymomatous myasthenia gravis, thymectomy plus prednisone confers benefits versus prednisone alone at five years, according to a study published online Jan. 25 in The Lancet Neurology.
More Severe Injuries Sustained at Jump Parks Versus Home Trampolines
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The proportion of fractures/dislocations, lower-extremity fractures, fractures in adults, and surgical interventions is higher for injuries associated with jump parks versus home trampolines, according to a study published in the Jan. 1 issue of the Journal of the American Academy of Orthopaedic Surgeons.
Evidence Lacking for Benefit of Surgery for Vertebral Fractures
MONDAY, Jan. 28, 2019 (HealthDay News) — Surgical procedures do not appear to provide significant benefit for patients with vertebral fractures (VF), according to a second American Society for Bone and Mineral Research Task Force report published in the January issue of the Journal of Bone and Mineral Research.
Paclitaxel Exposure in Vascular Device Not Linked to Mortality
MONDAY, Jan. 28, 2019 (HealthDay News) — Exposure to paclitaxel in drug-coated balloons used in procedures for the treatment of symptomatic femoropopliteal peripheral arterial disease is not associated with mortality, according to a study published online Jan. 25 in the Journal of the American College of Cardiology.
Comorbid Neck Injury Up for Women With Concussion